OncClub: Join the Chat on Trending Trials in Cancer 2023 nominations are open for Giants of Cancer Care® Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Subscribe to our eNewsletter for breaking news and curated content

OncClub: Join the Chat on Trending Trials in Cancer 2023 nominations are open for Giants of Cancer Care® Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Subscribe to our eNewsletter for breaking news and curated content

View More Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Hematologic Oncology Immuno-Oncology Lung Cancer Multiple Myeloma Urothelial Cancer

Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Hematologic Oncology Immuno-Oncology Lung Cancer Multiple Myeloma Urothelial Cancer

All Oncology News

Pipeline Report

OncClub All Oncology News Pipeline Report

Medical World News

OncLive News Network®

Thoracic Night Live

Insights Medical World News OncChats OncLive News Network®OncLive TV Peer Exchange Podcasts Rapid Readouts The Talk Thoracic Night Live

Conference Coverage

Conference Listing

Giants of Cancer Care

Scientific Interchanges

State of the Science Summit / IPC

Giants of Cancer Care PER Events Scientific Interchanges State of the Science Summit / IPC Webinars

Oncology Fellows

Supplements And Featured Publications

All Publications

OncologyLive Oncology Fellows Supplements And Featured Publications All Publications

Interactive Tools

Learning Modules

Interactive Tools Learning Modules Presentations Sponsored

Print Subscription

eNewsletter Print Subscription

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
2023 nominations are open for Giants of Cancer Care®
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Subscribe to our eNewsletter for breaking news and curated content

SpecialtySee All >

Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Multiple Myeloma
Urothelial Cancer

OncLive SOSS

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences^™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Inside the Clinic: Acute Graft-versus-Host Disease

EP. 1: Graft-Vs-Host Disease Explored

August 2nd 2019

EP. 2: Classifying GVHD and Predicting Risk of Events

August 2nd 2019

EP. 3: Acute Graft-Vs-Host Disease: Risk Factors

August 2nd 2019

EP. 4: Approaching Acute Graft-Vs-Host Disease

August 2nd 2019

EP. 5: Treating Acute GVHD: Systemic Corticosteroids

August 2nd 2019

EP. 6: Managing Steroid-Refractory Acute GVHD

August 2nd 2019

EP. 7: Ruxolitinib for Steroid-Refractory Acute GVHD

August 2nd 2019

EP. 8: Implications for Treating Acute GVHD With Ruxolitinib

August 2nd 2019

EP. 9: Fecal Microbiota Transplantation for Acute GVHD

August 2nd 2019

EP. 10: Novel-Based Approaches and the Future of Acute GVHD

August 2nd 2019

<
1
2
>

Advertisement

Advertisement